- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Biocon Chief Kiran Mazumdar Shaw, 2 others join USIBC Board as vice chairs
Washington: Three top corporate leaders, including Milind Pant, CEO of Amway and Kiran Mazumdar-Shaw, executive chairperson, Biocon, have joined the 2021 Global Board of Directors of US India Business Council (USIBC) as vice chairs.
Besides Pant and Mazumdar-Shaw, Edward Knight, vice chair, Nasdaq has also been inducted in the leadership team of the leading business advocacy organisation.
The induction of three top corporate leaders strengthens the USIBC's leadership team as the Council engages a new US administration and advocates for stronger US-India commercial ties in an increasingly complex world.
As vice chairs, Pant, Mazumdar-Shaw and Knight will work with USIBC president Nisha Biswal and the Council's policy directors to elevate priorities in critical sectors and lead meetings between industry and government, the USIBC said in a statement.
"I'm pleased to see the US-India Business Council elevate as Vice Chairs these captains of industry and forward-thinking business leaders," said Vijay Advani, USIBC Board of Directors chairman and executive chairman, Nuveen.
"Their perspectives will be invaluable as USIBC charts a path forward in the post-pandemic era and continues its work to deepen the US-India partnership," he said.
Honoured to step into this new role as a vice chair for the US-India Business Council's Board of Directors, Pant said that during his time at Amway, he had greatly valued the USIBC and its role in helping American companies operating in India.
"I look forward to the continued engagement in strengthening the US-India bilateral relationship in this role," he said.
They will work to amplify the voice of industry on international trade and investment issues and emphasise the critical role that businesses can play in strengthening democratic institutions and combatting the global pandemic, the statement said.
"As the world recovers from the global pandemic, the economic relationship between the United States and India has never been more important to Nasdaq and its listed companies. The US-India Business Council is a vital link between the two business communities and a proven facilitator of a productive dialogue between the US and Indian Governments," Knight said.
Mazumdar-Shaw said, "I am honoured to serve as a Vice Chair at the USIBC Board of Directors. USIBC has been committed to enhancing US-India bilateral trade and in my new role, I look forward to forging collaborative initiatives in Pharma & Healthcare in the area of research, innovation and skill development between our two nations."
The pandemic has provided a unique opportunity for robust engagement between the two nations that can lead to knowledge sharing in digital healthcare, medical technologies and IP-led drug and vaccine innovation to deliver healthcare solutions that can boost mutually beneficial bilateral trade, Mazumdar-Shaw said.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story